REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 459 filers reported holding REPLIGEN CORP in Q1 2021. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,877,150 | +1.4% | 244,495 | -9.8% | 0.26% | +8.6% |
| Q2 2023 | $38,336,367 | -6.1% | 271,005 | +11.7% | 0.24% | -15.6% |
| Q1 2023 | $40,844,809 | +20.1% | 242,604 | +20.8% | 0.29% | +10.3% |
| Q4 2022 | $34,009,300 | +9.3% | 200,870 | +20.8% | 0.26% | +6.1% |
| Q3 2022 | $31,107,000 | -18.0% | 166,248 | -28.8% | 0.25% | -17.4% |
| Q2 2022 | $37,941,000 | +38.8% | 233,626 | +60.7% | 0.30% | +70.9% |
| Q1 2022 | $27,342,000 | +148.5% | 145,369 | +156.8% | 0.18% | +157.4% |
| Q1 2021 | $11,003,000 | -30.5% | 56,598 | -31.5% | 0.07% | -27.7% |
| Q4 2020 | $15,836,000 | +24.8% | 82,638 | -3.9% | 0.09% | +14.6% |
| Q3 2020 | $12,689,000 | -56.9% | 86,003 | -63.9% | 0.08% | -59.4% |
| Q2 2020 | $29,432,000 | -7.1% | 238,103 | -27.4% | 0.20% | -27.6% |
| Q1 2020 | $31,683,000 | +52.3% | 328,184 | +45.9% | 0.28% | +88.5% |
| Q4 2019 | $20,802,000 | – | 224,884 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |